| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 900 | 2021 |
| Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group … C Comarmond, C Pagnoux, M Khellaf, JF Cordier, M Hamidou, JF Viallard, ... Arthritis & Rheumatism 65 (1), 270-281, 2013 | 895 | 2013 |
| Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the … C Pagnoux, R Seror, C Henegar, A Mahr, P Cohen, V Le Guern, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2010 | 580 | 2010 |
| Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies A Fischer, J Provot, JP Jais, A Alcais, N Mahlaoui, D Adoue, N Aladjidi, ... Journal of Allergy and Clinical Immunology 140 (5), 1388-1393. e8, 2017 | 300 | 2017 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 282 | 2021 |
| Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients S Georgin‐Lavialle, B Terrier, AF Guedon, M Heiblig, T Comont, E Lazaro, ... British Journal of Dermatology 186 (3), 564-574, 2022 | 237 | 2022 |
| Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis FL Besson, JJ Parienti, B Bienvenu, JO Prior, S Costo, G Bouvard, ... European journal of nuclear medicine and molecular imaging 38, 1764-1772, 2011 | 233 | 2011 |
| Efficacy and safety of epratuzumab in moderately to severely active systemic lupus erythematosus: results from two phase III randomized, double‐blind, placebo‐controlled trials MEB Clowse, DJ Wallace, RA Furie, MA Petri, MC Pike, P Leszczyński, ... Arthritis & rheumatology 69 (2), 362-375, 2017 | 230 | 2017 |
| Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sjögren's syndrome G Nocturne, A Virone, WF Ng, V Le Guern, E Hachulla, D Cornec, ... Arthritis & rheumatology 68 (4), 977-985, 2016 | 215 | 2016 |
| Management of giant cell arteritis: recommendations of the French Study Group for Large Vessel Vasculitis (GEFA) B Bienvenu, KH Ly, M Lambert, C Agard, M Andre, Y Benhamou, ... La Revue de medecine interne 37 (3), 154-165, 2016 | 198 | 2016 |
| Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy A Vendrely, B Bienvenu, J Gasnault, JB Thiebault, D Salmon, F Gray Acta neuropathologica 109, 449-455, 2005 | 196 | 2005 |
| JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis L Ladislau, X Suárez-Calvet, S Toquet, O Landon-Cardinal, D Amelin, ... Brain 141 (6), 1609-1621, 2018 | 195 | 2018 |
| Treatment of systemic necrotizing vasculitides in patients aged Sixty‐Five years or older: results of a multicenter, Open‐Label, randomized controlled trial of corticosteroid … C Pagnoux, T Quéméneur, J Ninet, E Diot, X Kyndt, B de Wazières, ... Arthritis & rheumatology 67 (4), 1117-1127, 2015 | 191 | 2015 |
| Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients C Charlier, C Henegar, O Launay, C Pagnoux, A Berezne, B Bienvenu, ... Annals of the rheumatic diseases 68 (5), 658-663, 2009 | 173 | 2009 |
| Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature MR Pokeerbux, J Giovannelli, L Dauchet, L Mouthon, C Agard, JC Lega, ... Arthritis research & therapy 21, 1-12, 2019 | 170 | 2019 |
| Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study E Hachulla, PY Hatron, P Carpentier, C Agard, E Chatelus, P Jego, ... Annals of the rheumatic diseases 75 (6), 1009-1015, 2016 | 166 | 2016 |
| Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature C Comarmond, B Crestani, A Tazi, B Hervier, S Adam-Marchand, ... Medicine 93 (24), 340-349, 2014 | 166 | 2014 |
| Suppression of CD4+ T lymphocyte effector functions by CD4+ CD25+ cells in vivo B Martin, A Banz, B Bienvenu, C Cordier, N Dautigny, C Bécourt, B Lucas The Journal of Immunology 172 (6), 3391-3398, 2004 | 165 | 2004 |
| Rationale and efficacy of interleukin-1 targeting in Erdheim–Chester disease A Aouba, S Georgin-Lavialle, C Pagnoux, N Martin Silva, A Renand, ... Blood, The Journal of the American Society of Hematology 116 (20), 4070-4076, 2010 | 155 | 2010 |
| Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis: a multicenter study from the French Uveitis Network H Vallet, P Seve, L Biard, J Baptiste Fraison, P Bielefeld, L Perard, ... Arthritis & rheumatology 68 (6), 1522-1530, 2016 | 149 | 2016 |
